Rajendra A Morey, Yuanchao Zheng, Henry Bayly, Delin Sun, Melanie E Garrett, Marianna Gasperi, Adam X Maihofer, C Lexi Baird, Katrina L Grasby, Ashley A Huggins, Courtney C Haswell, Paul M Thompson, Sarah Medland, Daniel E Gustavson, Matthew S Panizzon, William S Kremen, Caroline M Nievergelt, Allison E Ashley-Koch, Mark W Logue
{"title":"基因组结构方程建模揭示了人类大脑皮层中具有独特遗传结构的潜在表型。","authors":"Rajendra A Morey, Yuanchao Zheng, Henry Bayly, Delin Sun, Melanie E Garrett, Marianna Gasperi, Adam X Maihofer, C Lexi Baird, Katrina L Grasby, Ashley A Huggins, Courtney C Haswell, Paul M Thompson, Sarah Medland, Daniel E Gustavson, Matthew S Panizzon, William S Kremen, Caroline M Nievergelt, Allison E Ashley-Koch, Mark W Logue","doi":"10.1038/s41398-024-03152-y","DOIUrl":null,"url":null,"abstract":"<p><p>Genetic contributions to human cortical structure manifest pervasive pleiotropy. This pleiotropy may be harnessed to identify unique genetically-informed parcellations of the cortex that are neurobiologically distinct from functional, cytoarchitectural, or other cortical parcellation schemes. We investigated genetic pleiotropy by applying genomic structural equation modeling (SEM) to map the genetic architecture of cortical surface area (SA) and cortical thickness (CT) for 34 brain regions recently reported in the ENIGMA cortical GWAS. Genomic SEM uses the empirical genetic covariance estimated from GWAS summary statistics with LD score regression (LDSC) to discover factors underlying genetic covariance, which we are denoting genetically informed brain networks (GIBNs). Genomic SEM can fit a multivariate GWAS from summary statistics for each of the GIBNs, which can subsequently be used for LD score regression (LDSC). We found the best-fitting model of cortical SA identified 6 GIBNs and CT identified 4 GIBNs, although sensitivity analyses indicated that other structures were plausible. The multivariate GWASs of the GIBNs identified 74 genome-wide significant (GWS) loci (p < 5 × 10<sup>-</sup><sup>8</sup>), including many previously implicated in neuroimaging phenotypes, behavioral traits, and psychiatric conditions. LDSC of GIBN GWASs found that SA-derived GIBNs had a positive genetic correlation with bipolar disorder (BPD), and cannabis use disorder, indicating genetic predisposition to a larger SA in the specific GIBN is associated with greater genetic risk of these disorders. A negative genetic correlation was observed between attention deficit hyperactivity disorder (ADHD) and major depressive disorder (MDD). CT GIBNs displayed a negative genetic correlation with alcohol dependence. Even though we observed model instability in our application of genomic SEM to high-dimensional data, jointly modeling the genetic architecture of complex traits and investigating multivariate genetic links across neuroimaging phenotypes offers new insights into the genetics of cortical structure and relationships to psychopathology.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"14 1","pages":"451"},"PeriodicalIF":5.8000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502831/pdf/","citationCount":"0","resultStr":"{\"title\":\"Genomic structural equation modeling reveals latent phenotypes in the human cortex with distinct genetic architecture.\",\"authors\":\"Rajendra A Morey, Yuanchao Zheng, Henry Bayly, Delin Sun, Melanie E Garrett, Marianna Gasperi, Adam X Maihofer, C Lexi Baird, Katrina L Grasby, Ashley A Huggins, Courtney C Haswell, Paul M Thompson, Sarah Medland, Daniel E Gustavson, Matthew S Panizzon, William S Kremen, Caroline M Nievergelt, Allison E Ashley-Koch, Mark W Logue\",\"doi\":\"10.1038/s41398-024-03152-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Genetic contributions to human cortical structure manifest pervasive pleiotropy. This pleiotropy may be harnessed to identify unique genetically-informed parcellations of the cortex that are neurobiologically distinct from functional, cytoarchitectural, or other cortical parcellation schemes. We investigated genetic pleiotropy by applying genomic structural equation modeling (SEM) to map the genetic architecture of cortical surface area (SA) and cortical thickness (CT) for 34 brain regions recently reported in the ENIGMA cortical GWAS. Genomic SEM uses the empirical genetic covariance estimated from GWAS summary statistics with LD score regression (LDSC) to discover factors underlying genetic covariance, which we are denoting genetically informed brain networks (GIBNs). Genomic SEM can fit a multivariate GWAS from summary statistics for each of the GIBNs, which can subsequently be used for LD score regression (LDSC). We found the best-fitting model of cortical SA identified 6 GIBNs and CT identified 4 GIBNs, although sensitivity analyses indicated that other structures were plausible. The multivariate GWASs of the GIBNs identified 74 genome-wide significant (GWS) loci (p < 5 × 10<sup>-</sup><sup>8</sup>), including many previously implicated in neuroimaging phenotypes, behavioral traits, and psychiatric conditions. LDSC of GIBN GWASs found that SA-derived GIBNs had a positive genetic correlation with bipolar disorder (BPD), and cannabis use disorder, indicating genetic predisposition to a larger SA in the specific GIBN is associated with greater genetic risk of these disorders. A negative genetic correlation was observed between attention deficit hyperactivity disorder (ADHD) and major depressive disorder (MDD). CT GIBNs displayed a negative genetic correlation with alcohol dependence. Even though we observed model instability in our application of genomic SEM to high-dimensional data, jointly modeling the genetic architecture of complex traits and investigating multivariate genetic links across neuroimaging phenotypes offers new insights into the genetics of cortical structure and relationships to psychopathology.</p>\",\"PeriodicalId\":23278,\"journal\":{\"name\":\"Translational Psychiatry\",\"volume\":\"14 1\",\"pages\":\"451\"},\"PeriodicalIF\":5.8000,\"publicationDate\":\"2024-10-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502831/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41398-024-03152-y\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-024-03152-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
人类大脑皮层结构的遗传贡献表现出普遍的多义性。这种多效性可能被用来识别大脑皮层中独特的遗传学划分,这些划分在神经生物学上有别于功能、细胞结构或其他大脑皮层划分方案。我们通过应用基因组结构方程建模(SEM)来绘制最近在 ENIGMA 皮质 GWAS 中报告的 34 个脑区的皮质表面积(SA)和皮质厚度(CT)的遗传结构图,从而研究遗传多效性。基因组 SEM 利用通过 LD 评分回归(LDSC)从 GWAS 概要统计中估算出的经验遗传协方差来发现潜在的遗传协方差因素,我们将其称为遗传信息脑网络(GIBNs)。基因组 SEM 可以根据每个 GIBNs 的汇总统计数据拟合多变量 GWAS,然后将其用于 LD 分数回归(LDSC)。我们发现,皮层 SA 的最佳拟合模型确定了 6 个 GIBN,CT 确定了 4 个 GIBN,尽管敏感性分析表明其他结构也是可行的。GIBN 的多变量 GWAS 发现了 74 个全基因组显著(GWS)位点(p -8),其中包括许多以前与神经影像表型、行为特征和精神状况有关的位点。GIBN GWAS 的 LDSC 发现,SA 衍生的 GIBN 与双相情感障碍(BPD)和大麻使用障碍有正的遗传相关性,这表明特定 GIBN 中较大 SA 的遗传易感性与这些障碍的更大遗传风险相关。注意缺陷多动障碍(ADHD)和重度抑郁障碍(MDD)之间存在负遗传相关性。CT GIBN 与酒精依赖呈遗传负相关。尽管我们在将基因组 SEM 应用于高维数据时观察到了模型的不稳定性,但对复杂性状的遗传结构进行联合建模以及对神经影像表型的多变量遗传联系进行研究,为了解大脑皮层结构的遗传学及其与精神病理学的关系提供了新的视角。
Genomic structural equation modeling reveals latent phenotypes in the human cortex with distinct genetic architecture.
Genetic contributions to human cortical structure manifest pervasive pleiotropy. This pleiotropy may be harnessed to identify unique genetically-informed parcellations of the cortex that are neurobiologically distinct from functional, cytoarchitectural, or other cortical parcellation schemes. We investigated genetic pleiotropy by applying genomic structural equation modeling (SEM) to map the genetic architecture of cortical surface area (SA) and cortical thickness (CT) for 34 brain regions recently reported in the ENIGMA cortical GWAS. Genomic SEM uses the empirical genetic covariance estimated from GWAS summary statistics with LD score regression (LDSC) to discover factors underlying genetic covariance, which we are denoting genetically informed brain networks (GIBNs). Genomic SEM can fit a multivariate GWAS from summary statistics for each of the GIBNs, which can subsequently be used for LD score regression (LDSC). We found the best-fitting model of cortical SA identified 6 GIBNs and CT identified 4 GIBNs, although sensitivity analyses indicated that other structures were plausible. The multivariate GWASs of the GIBNs identified 74 genome-wide significant (GWS) loci (p < 5 × 10-8), including many previously implicated in neuroimaging phenotypes, behavioral traits, and psychiatric conditions. LDSC of GIBN GWASs found that SA-derived GIBNs had a positive genetic correlation with bipolar disorder (BPD), and cannabis use disorder, indicating genetic predisposition to a larger SA in the specific GIBN is associated with greater genetic risk of these disorders. A negative genetic correlation was observed between attention deficit hyperactivity disorder (ADHD) and major depressive disorder (MDD). CT GIBNs displayed a negative genetic correlation with alcohol dependence. Even though we observed model instability in our application of genomic SEM to high-dimensional data, jointly modeling the genetic architecture of complex traits and investigating multivariate genetic links across neuroimaging phenotypes offers new insights into the genetics of cortical structure and relationships to psychopathology.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.